Lv31
268 积分 2023-07-16 加入
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
1天前
待确认
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
2天前
已完结
Oncolytic viruses: a new class of immunotherapy drugs
6天前
已完结
Newcastle disease virus as an oncolytic agent
7天前
已关闭
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
9天前
已完结
Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable gastric/gastroesophageal junction cancer (GC/GEJC)
9天前
已关闭
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model
11天前
已完结
Textbook of Influenza
11天前
已完结
Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
15天前
已完结
Herpes simplex virus Membrane Fusion
16天前
已完结
皖公网安备34019202002308
